We are live on ! Find out more
QTTB icon

Q32 Bio

86 hedge funds and large institutions have $588M invested in Q32 Bio in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

300% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 10

30% more funds holding

Funds holding: 6686 (+20)

0.41% more ownership

Funds ownership: 3.42%3.83% (+0.41%)

8% less capital invested

Capital invested by funds: $640M → $588M (-$52.4M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
86
Holders Change
+20
Holders Change %
+30.3%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
40
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GTC
26
Ghost Tree Capital
New York
$2.45M +$2.73M +6,944 New
PC
27
Polar Capital
United Kingdom
$1.96M
Ameriprise
28
Ameriprise
Minnesota
$1.86M -$68K -173 -3%
N
29
Nuveen
North Carolina
$1.78M +$1.98M +5,049 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.7M +$529K +1,347 +39%
HAM
31
HHR Asset Management
New Jersey
$1.66M +$1.85M +4,714 New
Alyeska Investment Group
32
Alyeska Investment Group
Illinois
$1.44M +$1.6M +4,079 New
SSA
33
Schonfeld Strategic Advisors
New York
$1.17M +$1.31M +3,328 New
LCM
34
Laurion Capital Management
New York
$1.01M +$1.13M +2,869 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$942K +$442K +1,125 +73%
Citigroup
36
Citigroup
New York
$918K +$914K +2,327 +828%
Bank of America
37
Bank of America
North Carolina
$916K +$266K +676 +35%
Two Sigma Investments
38
Two Sigma Investments
New York
$892K +$995K +2,533 New
Citadel Advisors
39
Citadel Advisors
Florida
$826K +$922K +2,345 New
Goldman Sachs
40
Goldman Sachs
New York
$792K -$78.6K -200 -8%
Rafferty Asset Management
41
Rafferty Asset Management
New York
$750K +$836K +2,128 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$733K +$243K +619 +42%
Swiss National Bank
43
Swiss National Bank
Switzerland
$708K +$284K +722 +56%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$535K +$140K +357 +31%
CCM
45
Consonance Capital Management
New York
$512K +$571K +1,453 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$489K +$170K +433 +45%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$474K +$10.6K +27 +2%
AllianceBernstein
48
AllianceBernstein
Tennessee
$454K +$91.6K +233 +22%
HLA
49
Hamilton Lane Advisors
Pennsylvania
$447K +$498K +1,268 New
SIM
50
Spark Investment Management
New York
$444K -$450K -1,144 -48%

QTTB Hedge Fund Activity: Q2 2019 in Review

86 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2019, worth a combined $588M — down 8.2% from $640M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new QTTB positions and 6 closed out — a net gain of 23 holders — while 40 added to existing stakes and 10 trimmed.

The largest buyer was Bellevue Group, opening a new position worth an estimated $30.6M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $4.46M sold.

  • 86 institutional investors held Q32 Bio (QTTB) as of Q2 2019, up from 66 in Q1 2019.
  • Funds reported $588M of Q32 Bio stock for Q2 2019, down 8.2% quarter-over-quarter.
  • 29 funds opened new Q32 Bio positions in Q2 2019 and 6 closed out, a net change of +23 holders.
  • The largest Q32 Bio buyer in Q2 2019 was Bellevue Group, an estimated $30.6M added.
  • The largest Q32 Bio seller in Q2 2019 was Sphera Funds Management, an estimated $4.46M sold.

Based on aggregated 13F filings for Q2 2019.